Tandem Diabetes Care Inc. won the FDA’s approval for its t:slim insulin delivery system under a revised approval process that aims to create a less expensive, more predictable and overall speedier path to commercialization for medical devices.

Tandem Diabetes Care Inc. won the FDA’s approval for its t:slim insulin delivery system under a revised approval process that aims to create a less expensive, more predictable and overall speedier path to commercialization for medical devices.

The head of the Food and Drug Administration’s medical device unit stopped in San Diego last week for a series of one-on-one meetings with some of the area’s largest device makers, including ResMed Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99